Company: COPL-UN
Filing Date: 2025-02-03
Form Type: S-1/A
Source: 0001829126-25-000620
Chunk: 124

Company: Copley Acquisition Corp
Filing Date: 2025-02-03
Form: S-1/A
Chunk 124
---
 than the market value of your warrants.

Our management’s ability to require holders of our warrants to exercise such warrants on a cashless basis will cause holders to receive fewer Class A ordinary shares upon their exercise of the warrants than they would have received had they been able to exercise their warrants for cash.

If we call our public warrants for redemption after the redemption criteria described elsewhere in this prospectus have been satisfied, our management will have the option to require any holder that wishes to exercise his warrant (including any warrants held by our sponsor, officers or directors, other purchasers of our placement units, or their permitted transferees) to do so on a “cashless basis.” If our management chooses to require holders to exercise their warrants on a cashless basis, the number of Class A ordinary shares received by a holder upon exercise will be fewer than it would have been had such holder exercised his warrant for cash. This will have the effect of reducing the potential “upside” of the holder’s investment in our company.

<div align='center'>79</div>

Our warrants and founder shares may have an adverse effect on the market price of our Class A ordinary shares and make it more difficult to effectuate our initial business combination.

We will be issuing warrants
to purchase 7,500,000 of our Class A ordinary shares (or up to 8,625,000 Class A ordinary shares if the underwriters’ over-allotment
option is exercised in full), at a price of $11.50 per share (subject to adjustment as provided herein), as part of the units offered
by this prospectus and, simultaneously with the closing of this offering, we will be issuing in a private placement an aggregate of 387,500
placement units (up to 426,875 placement units if the over-allotment option is exercised in full). The placement units will include warrants
to purchase an aggregate of 193,750 (or 213,438 if the over-allotment option is exercised in full) Class A ordinary shares at $11.50
per share, subject to adjustment as provided herein. In addition, in order to fund working capital deficiencies, finance transaction
costs in connection with an intended initial business combination, and cover the cost of the extension options, our sponsor or an affiliate
of our sponsor or certain of our directors and officers may, but are not obligated to, loan us funds as may be required. Such loans may
be convertible into units at a price of $10.00 per unit at